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The heparin affinity of normal and two PI variants of antithrombin-lll CAT) was studied by sradient elad0n with NaCI in Tris buffer on hcparin- 
Sepharose, At pH 7,4 normal AT eluted at [Na °1 0.78 mol/I and the variants both showed increased affinity with AT Pescara elating at [Na'] 
0.86 moltl and AT Glasgow at [Na'] 0,92 molll. We have earlier proposed a model for heparin activation in which the ative state of AT maintains 
a salt bridge involving the PI Arg-393 residue. Binding ofheparin i duces a higher parin affinity conformation in which the salt bridge is disrupted 
to reveal the reactive centre for inhibitio~ of thr0mbin. The Glasgow and Pescara variants, lacking a reactive centre P! basic residue, would b¢ 
unable to form this t~tlt bridge, and we suggested that the high affinity confomtation which they adopt as their native state would resemble the 
heparin induced conformation. To examine this model, we measured the heparin induced fluorescence of two P [ variants and tested the susceptibility 
of their reactive loops to catalytic cleavage. Both variants had fluore~cnee spectra indistinguishable from normal AT. In the a ~scnee of heparin, 
neither variant was more susceptible han normal to catalytic cleavage by human eutra phil elastase. These findings suggest that the conformation 
of these PI variants i different to that of fully heparinizcd normal AT, 
Antithrombin; Heparin binding; Reactive site mutant 
1. INTRODUCTION 
AT is the major physiological inhibitor of thrombin, 
"The rate of inhibition is slow in the absence of heparin, 
but on binding to heparin AT undergoes a conforma. 
tional change to give a configuration that r pidly reacts 
with target proteases and inactivates them. 
Three main approaches have been taken to define the 
region of AT that is involved in heparin binding: (i) the 
characterisation f the mutations in AT variants that 
have reduced heparin binding affinity [2,3]; (ii) the 
identification of uniquely conserved basic residues in 
the homologous heparin binding serpins, heparin co- 
factor.I I, AT, and pretense nexin-1 [4,5]; (iii)the labell- 
ing of lysine residues in the presence and absence of 
heparin [6]. The cumulative r sults of these xperiments 
show the primary heparin binding site to be a zone ex- 
tending along the underside of the D-helix up towards 
the large t3-sheet structure [3-5]. 
Somewhat less clear is the mechanism by which bin- 
ding of heparin to antithrombin results in the activation 
of the inhibitor. Heparin is presumed to induce a con- 
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formational change in AT from an inactive to an active 
form. The evidence for this has come from studies uch 
as heparin-induced changes in the fluorescence spectra 
[7], or circular dichroism [8], and the heparin affinity of 
P1 variant antithrombin Glasgow 393 Arg to His [1]. 
At pH 7.4, AT Glasgow has an increased affinity for 
heparin but at pH 6.0 with the protonation of the 
histidine this reverts to normal. On the basis of these 
studies, we have suggested that an ionic bond is formed 
with the positively charged Arg-393 and that this plays 
a role in maintaining AT in a constrained, non- 
activated configuration, When heparin binds at the bin- 
ding site, the induced conformational change that is 
transmitted to the reactive centre, results in the disrup- 
tion of this ionic bond. Thus, as a consequence, the 
reactive loop is freed to interact with target proteases in
the heparin activated conformation. It was also sug- 
gested that the loss of this charged residue in PI 
variants of AT results in a conformation more like the 
heparin activated form. This model predicts that all the 
P1 variants which are unable to form this ionic bond 
will have an increased heparin affinity. To date two 
other PI variants have been identified, AT Northwick 
Park (393 Arg to Cys) [9] and AT Pescara (393 Arg to 
Pro) [10]. The first of these has been reported to have 
an increased affinity. Here vce report he heparin affini- 
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ty, at pH "/.4, or AT Pe~eara relative to normal AT and 
~T G la~llow. 
It is alxo known th=tt heparln accderme~ inactivation 
of AT by catalytic clezvaile of ill reactive loop. Thus in 
lhe pre~ence of hepnrifl normal AT is very ~u~ceptible to
proteolytic cleavage will] human neutrophil elaslase 
which occurs either side of residue 391 (P4) [111. i(, rite 
absence of heparin, the PI variants of AT are already in 
the heparin e.clivated conformation due to lheir inabili- 
ty to formthe PI ionic bond, they would be expected to 
be more susceptible than normal AT to calalylic 
cleavage of the reactive loop. This paper reports the 
results of experiments zo test this prediction. 
2. MATERIALS AND METHODS 
~. I. [lel)llr~n.~'PplNIr~.~¢ ¢llrollllllollrcl/3h,v Ol IJH F,# 
To 10 ml of plasma wn~ added O, 1 ml or 10% dcstran ~,tllplt;tte (~.:1, 
500 (R30) anti O, I ml of 5 m,.~lll C'ttCl~, The sup<rnalant wa~ loaded on, 
to a hepatii~,Sepharo~¢ eohmm (0,9 x 15 era] e¢luilibrated with O,O.~ 
molll Tris, 0,01 mol/l citrate. 0.1~; mol/l NaCI. ptl  7,4, The AT~ 
wer~ ¢luted with a linear NaCI ~,radicnt to 1.6:S tool/I, slartintz ~vi~l~ 
210 ml of each burrer [2]. 
2,2 DEA~..5"epheMe,v A.$(1, pH &6 
F.rther purification of AT and tile removal of trace amounts of 
ehtted heparin ~ere accomplished by chromatography on DEAE- 
Sephadex A.50, DII I~,6. ~lntin~, with a linear iFatlicnt to, 0,45 moWI 
NaCI [21, 
2,3, ~'leClrollttltlltllO (/,~$~1)' of coltltno frrlclions 
A I mm thick pla~¢ was poured from' 30 ml of 1% aBarose in "/5 
mmol/ l  Tris/Glyeine/Barbitone barfer pH 8,6, ¢ontaininl~ 150 td of 
Dako antiserum to .AT, A 3 Id volume from each fraction wa~ loaded 
Hepar in -Sepharose  Chromatography  pH 7.4 
Into Ih~ wc'lh and d¢¢lrophor~.*~it rr lcd out .I I$fl V for 6 h. Plal~ 
~'re pre~¢d, drlcd ~.d ~t~lncd with C'ooma,~i¢ bht~ il.~l. 
],4, ~H/t~tro~¢ Jt¢t ¢l¢¢leophor~,~i~ at pl l  tt;6 
Thl~ ~. .  earrt,:d ottt a~ d¢~¢tibed pr~vloudX 12l. 
2,$, Sodium ion ¢oncenlralh~lt~ 
Th~'  ~r~ p~rl'or~ncd on pooled p~ak~ from hcparln-$~pharo~ 
chrom~tlOlJraph), on ;t Hil~a~:h| an~lyler, m~lel Tl'/, u~lnll ttn ion 
~po:tri~ d¢¢trod¢. 
2.a. :Sl}.~.Pol.ra~r.vhmtide actelerlrophor¢~i~¢ 
Thi~ was earrl~'d ill i .  10% ltd~ u~ir, t~ the method of Ll~emmli I I ~), 
n,-1, ~tlal.vlt¢" ¢i¢avo~i¢ of  A T with human ttentroPhll ~tastas~ 
Purified AT (normal, C;Ins~ow and P~ara variants) wa~ inettb~t~d 
at ~'/-~C' with haman neutrophil da~tase Itt ttirt from Dr IVl. Vt~er~) at 
n tna~ ratio or 1:2~0 (ela~ta~e~'AT), witlt and wilhout hcparin, anti 
~ample.s were laken at tinted Interval~, The aliquot~ were tmmedinldy 
boiled witl~ an eqaal volnnte of SDS ~ampl~ barfer conlalnlnll met. 
captoethnnol, mRI analy~d by SDS.poiyaer>'lamide lid dee. 
trophore~i~. 
In detail, the incubation ~ixture witl~ heparin comprised 17 ~t~ an. 
t itllrombin, 0,068/~M human nemrophil ela~ta~e and ~ U or heparin il 
di~olved in 100/d or 0.Ol mol/I Trt~, 0,03 mol/I NaCI. 1,~ mmol/I 
t¢...1210"I'A, pH 8,4, I:~ ~1 aliquot~ were taken at 0, I, ~. 3~,  l0 anti 20 
rain, The misture wid~out heparin contained the tame amoants of AT 
anti elastase nnd buffer, but in place or heparin contained 5 ~,8 of pro. 
famine sulphate. 15 t,I aliq uots were taken at 0, l, 2, 3, t0.20 and 60 
mitt. Tile possible presence of ¢ontaminatin8 proteinas¢~ in the 
eia~tase prcp:traflon wa~ tested for b), incubatin8 the elastas¢ firstly 
with a ~pe¢lrie lasta~e inhibitor, Methoxy succinyI.Ala.Ala-Pro.Val- 
ehloromethy I ketone at a molar ratio of I:100. AT was then incubated 
with this preparation i the presence of heparin anti aliquot~ taken at 
limed Jnl~'rvahi ,'Is abo~,e. 
2.8. Fluorescence emtssion spectra of normal, Glasgow and PesetuY~ 
A T ,vilh and without heparin at pH 7.4 and 6.0 
'rile method follows that or Olson [7], Measurements were per- 
formed in an Aminco Bowman speetrofluorimeter witla excitation at 
280 nm and emission from 310 to 410 nm, Measurements at pH "/.4 
were performed in phosphate buffered s:tline, and at pH 6.0 in 0,01 
mol/I EDTA. 0.01 mol/l citrate buffer, 
AT was added to 2 ml of buffer to give a Final concentration of
about 50 #g/ml, Spectra were performed with no added heparin, and 
with 1,5 U, 3 U, 10 U and 20 U. Spectra were also produced for buff'er 
blanks, 
a 
Fig, 1, Electroin~munoassay for antithrombin (AT) in fractions from 
chromatography of plasma from patients with normal AT. ,AT 
Pescara nd AT Glasgow on heparin-Sepharose at pH 7,4, Tile insert 
shows electrophoresis in agarose gel at pH 8.6 of fractions a, b, c and 
d pooled from the heparin-Sepl~arose chromatography of AT Pescara 
and AT Glasgow patients' plasma, Normal human serum is run as a 
reference in tile first and last lanes, 
3. RESULTS 
3.1. Heparin binding affinity 
The fractions from the heparin-Sepharose columns 
of normal, Pescara and Glasgow plasmas were analysed 
by electroimmuno assay. These results (Fig. 1) show 
that for the Glasgow sample AT elutes as two distinct 
peaks, whereas Peseara plasma has a broadened peak 
with a trailing edge, and normal plasma an almost sym- 
metical peak. Agarose gel electrophoresis of the pooled 
first half of the Pescara peak (Fig. la), and the pooled 
second l ia l f  (Fig. lb )  demonst ra tes  that  the  var iant  p ro -  
te in  is e lec t rophoret i ca l ly  fas ter  runn ing ,  and  e lutes at  a 
h igher  ion ic  s t rength  than  the normal  component .  The  
reso lu t ion  fo r  G lasgow is a lmost  complete ,  w i th  the  ear -  
ly peak  (F ig.  lc)  ident i f ied  by  e lec t rophores i s  as the  nor -  
ma l  AT  component ,  and  the  la ter  peak  (F ig.  Id)  as the  
var iant .  The  sod ium ion concent ra t ion  o f  the  f rac t ion  
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Fig, 2, SDS.poi:cac,'.vhtmide or purified normal AT (~t and b}, trod Ghts$ow varinnt (e and d} ,',mtl Pe~t:~trtt vari.mt (eaml  13 its 11 control (C} nnd 
:is incubated with huotan eutrtH~hi| dastitse and snmptcd at'times 0. I, 2, 3, $, I0, 20 and 60 rain as shown. Gels a, c ,and e were from il~cttbations 
in tl~c prcsettce of  heparin, and ttels b. d a .d  r i~ the absence, Mole,zular weight markers (M) corresl~ond to p~otcins or 3I, tin kDM 116, 97, 68, 
4~ mtd 29 from top to bottom of I~el rcspectivel)'. Lane 2 in gel b i~ tl~nOred ;t~ an artir¢tct. 
containing normal AT was 0.78 real/i; the Pescara 
variant (b) 0.86 real/I, and the G[asgow variant (d) 0,92 
real/l, 
3.2. Cleavage with human neutrophil elastase 
The human neutrophil elastase contained negligible 
contaminating proteinases. Incubation of  AT and 
heparin with elastase pretreated with the inhibitor 
showed very little reaction after 20 rain, with maybe 
2-3% of the protein being cleaved, 
3,2,1. Normal AT. In the presence of heparin (Fig. 
2a) proteolytic inactivation proceeds rapidly. There is 
often an initial formation of  a higher Mr band which by 
1 rain comprises ome 70070 of the AT. This is then fur- 
ther degraded to give a lower M, producL At 20 nfin 
about 70°7o f the AT has been degraded to the lowMr 
product. In contrast, the reaction is very much slower in 
the absence of heparin (Fig; 2b) and proceeds with a 
slow production of the low M~ product. At 20 min only 
about 10070 of the AT has been degraded to the low M~ 
product. 
3.2.2. A T Glasgow. In the presence of  heparin (Fig, 
2c) there is conversion to a higher M~ band which is 
complete by about 5 min (cf. normal, about 2 rain). 
However, there is no further degradation to the lower 
Mr band. In the absence of  heparin (Fig. 2d) there is 
very little reaction, or change, over the 60 rain. 
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3.2.3. AT Pescara. In the presencc of heparin (Fig, 
2c) there is the formation of  a higher M, which then 
degrades to a low M~ band, as in normal AT However, 
the reaction is much slower, probably about 20% that 
of normal, AT 10 rain Pescara has a similar pattern to 
normal AT at 1-2 rain. In the absence of lteparin (Fig. 
2f) there ts essentially no reaction over 60 rain. 
3.3. Fhtorescence emission spectra q]'norntal, Glasgow 
and Pescara 
The fluorescence spectra of normal AT at pI-I 7.4 and 
6.0 is shown in Fig. 3a, With the addition of heparin, 
the peak at 347 nm increases until an optimal beyond 
which no further increase occurs. The fluorescence 
enhancement with heparin was calculated from the 
change in the fluorescence at the 347 nm peak, allowing 
for the non-AT fluorescence in the buffer blank, (defin- 
ing the baseline at 400 nm). For normal AT the change 
was 58°70 at pH 7.4 and 26°70 at pH 6,0, Similarly for 
AT Glasgow (Fig. 3b) and Pescara (spectra not shown) 
the corresponding change was 58070 at pH 7.4 and 25°70 
at pH 6.0. 
4. DISCUSSION 
We set out to test 3 predictions that stem from our 
earlier proposal [1] concerning the role of the Pl active 
site residue in the activation of  AT by heparin Heparin 
gluoreaeen©e Emlulon Spectra 
;*- .~ 
~ii!!il 
~'",~i, ,'.?!!![ii!~i!!ii~!i~ili i;iili~ 
Normal 
"; . . . . . . . . . . . . . . . . .  ,'" "T".'S'. Y " -  . . . . . .  ,'-., , ,--.'.'.'.'~" , ,-'c'r ,-, ,;, ; -~  : r': 
I ~ ~ I : I "  "" '~ ~ " 'A .... ~ ' : ' "~ '~ l~"~ 
310 350 400 
Wavelength (am) 
I':ig. 3 I:luorcscence emis.~ion spectra 'of purified normal (a) and AT 
Glasgow (b) al pH 6.0 :rod 7;4. Excitation was a~ 280 nm and ~pcctra 
were run in the absence of heparin and with the addition of 1,5, 3, 6, 
l0 :ltld 20 U, as showll Oll he traces. 
binds to AT and induces a conformational change from 
tran~mitted t~ the reactive ¢~lr~ ~li~rup|inll |his ionize 
bond, Tlli~ wo~ld then free the re~idue~ in the reactNe 
centre loop for interaction with prOtCa~er~, The Io~.~ of 
the chartled PI AR~-39~ w~ts predicted to result in a 
conformation mor~ like the heparin activated form. 
Thi~ model would predict firstly, chal all PI varlant~ 
which are unable to form thi,~ ionic bond will have a.n 
increased heparin affinity, S~:ondly~ it follows theft 
even in ¢l~e absence of heparin these PI variants hould 
be suscepUble to catalytic cleavage by elastase, Thirdly, 
if the conformation of tl~se variants was like the ac- 
tivated form, then they .thould display a reduced 
flnoreseem:~ enhancement o~ the addition of hepann, 
4, I. IYeparin btndht~l o f  P I  variants 
Both AT Glasgow and AT Pescara have increased 
heparin bindin@ affinity. Compared with normal ,~T 
which elules at 038 molll [Na'] ,  Glasgow elutes at 
0.92 mol/I [N'.~'] and Pescara at 0.86 molll [Na" 1, 
Althoul~h we I~ave not been able 1o measure the heparin 
affinity of AT Northwiek Park, 393 Arg to Cys, under 
these conditions, it has been reported to have an in-  
creased hepadn affinity [14]. Thus, =all the reported PI 
variants have an increased heparin affinity. Further, we 
have previously shown that protonation of the PI 
histidine in AT Glasgow at pH 6.0 results in tt~e heparin 
affinity reverting to normal, Colle~:tively, these results 
imply that the P! residue plays a critical role in main- 
raining the normal non-activated conformation. A role 
that is consistent with a residue requiring a positive 
charge is its involvement m an iomc bond, ,%AT lacks 
a carbohydrate side chain at Asn-135 which results in an 
increase in heparin binding affinity. However, the 
higher heparin affinity of AT Pescara nd Glasgow can 
not be explained by the lack of a carbohydrate side 
chain since they have molecular weights identical to 
normal AT. 
4,2, Catalytic cleavage by elastase 
In the absence of lael3arin, AT is relatively resistant to 
inactivation by cleavage of the reactive centre loop by 
human neutrophil elastase (Fig, 2b). This is consistent 
with our proposal that in this conformation an ionic 
bond is formed with the positively charged Arg-393 and 
the adjacent residues would also be protected from pro- 
teolysis. Similarly in this conformation the PI residue is 
unavailable, or inappropriately orientated, for interac- 
tion with the target enzymes, thrombin or Factor Xa. In 
an inactive to an active form. AT Glasgow, 393 Arg to  the presence of heparin, the resultant conformational 
His, has an increased affinity for heparin, but this 
reverts to normal at pH 6.0. Thus, we suggested, the 
positively charged Arg-393 plays a role in maintaining 
AT in a constrained, lower heparin affinity conforma- 
flora. This conformation is stabilized by an ionic bond 
involving the PI Arg residue. So, we reasoned, when 
heparin binds to AT at its primary l~nding site along the 
D-helix, there is a conformational change that is 
change gives a form in which the reactive centre loop is 
both available for interaction with thrombin or Xa and 
is very susceptible to catalytic cleavage by elastase (Fig. 
2a). If this ionic bond contributes to maintaining the 
non-activated conformation, then variants unable to 
form thc ionic bond could be expected to be susceptible 
to catalytic leavage of the reactive loop in the absence 
of heparin. However, the results of incubating AT 
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GMsjow anti AT Peieara with elastase in tht~ absem:e of 
heparin do not show increased susceptibility to 
cleavalle. Althoulzh thi~ may mean that the model pro- 
posed i~ inappropriate, interpretation f  the data is 
complicated by the lack of proteolytic dellradation even 
in the presence of heparin. Possibly these mutations 
have a different effect olt the conformation of the reac- 
tive centre loop, This situation can easily be conceived 
as applying for AT Pescara where the replacement ofan 
artlinine for a proline, an amino acid, would be ex- 
pected to constrain the preceding loop in such a way 
that the effects are not easy to predict, However, AT 
Glasgow, with a histicline, would not be expected to 
produce ~ similar structural con st ralnt. We have found 
that AT Glasgow with or without heparin does not in- 
hibit elastasc even at the catalytic ratios used in the 
catalytic leavage xperiments, Hence the lack of pro- 
teolytic degradation of Glasgow is not explicable in this 
way, 
4,3, Fluoresce/tee nhancement with heparin 
As AT Glasgow at pH 7.4 is in a high heparin affinity 
conformation, it might be expected to have a reduced 
fluorescence enhancement with heparin, compared with 
normal AT, However, the results of these experiments 
slmw, at pH 7.4, identical fluorescence enhancement of 
58°70 with normal and Glasgow, At pH 6.0, with the PI 
residue charged in Glasgow, as expected from the 
model, the results are essentially identical; normal 26% 
enhancement and Glasgow 25%, These results may be 
interpreted as showing that the change in fluorescence 
induced by heparin binding is a direct consequence of
heparin being bound adjacent o a critical tryptophan 
(e.g. residue 49). This is unlikely because other evidence 
[7] suggests the enhancement is due to a buried 
trytophan, probably 225. The enhancement then would 
be due to the same conformation change occurring in 
Glasgow and normal. The results do suggest hat the 
high affinity conformation of AT Glasgow and Pescara 
(i.e. in the absence of heparin) is not similar to the 
heparm induced conformation of normal AT. The 
results do not preclude there being a localized confof  
mational difference, between Glasgow and normal, that 
is not reflected in a change in fluorescence enhance- 
mont, 
Heparin binding to AT results in the P1 residue 
ehanllin$ from a relatively inaccessible position, with 
rot, peel to its tarllet protease, to a very accessible po.si. 
lion, With this change, the reactive loop hecome~ ac. 
¢essible to cleavage by elastase. Th,~ resistance of the P I 
variants to elastase in the ab.senc¢ of heparin doe~ not 
preclude the invohement of  a P i ionic bond. but show~ 
that the conformation of tl~ese PI v~riants is not the 
same as the normal heparin activated conformation, 
The chanties which result in the increase heparin bin. 
din~ affinity of Pl variants are not identical to the ma. 
jor change in conformation that occurs on heparin bin. 
di118, 
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